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Abstract
Background: Hepatic regeneration requires coordinated signal transduction for efficient restoration of
functional liver mass. This study sought to determine changes in lysophosphatidic acid (LPA) and LPA
receptor (LPAR) 1–6 expression in regenerating liver following two-thirds partial hepatectomy (PHx).
Methods: Liver tissue and blood were collected from male C57BL/6 mice following PHx. Circulating LPA
was measured by enzyme-linked immunosorbent assay (ELISA) and hepatic LPAR mRNA and protein
expression were determined.
Results: Circulating LPA increased 72 h after PHx and remained significantly elevated for up to 7 days
post-PHx. Analysis of LPAR expression after PHx demonstrated significant increases in LPAR1, LPAR3
and LPAR6 mRNA and protein in a time-dependent manner for up to 7 days post-PHx. Conversely,
LPAR2, LPAR4 and LPAR5 mRNA were barely detected in normal liver and did not significantly change
after PHx. Changes in LPAR1 expression were confined to non-parenchymal cells following PHx.
Conclusions: Liver regeneration following PHx is associated with significant changes in circulating LPA
and hepatic LPAR1, LPAR3 and LPAR6 expression in a time- and cell-dependent manner. Furthermore,
changes in LPA–LPAR post-PHx occur after the first round of hepatocyte division is complete.
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Introduction
Liver regeneration is the process by which functional hepatic
tissue is restored following damage or loss in liver mass.1–3 In the
clinical setting this is most commonly observed following the
resection of a hepatic tumour or after a repair following trauma.2,3
In the laboratory these clinical observations can be modelled,
most commonly in mice and rats, by the administration of
hepatotoxins (e.g. carbon tetrachloride) or by the surgical removal
of one or more lobes of the liver in partial hepatectomy (PHx).3,4
Although both approaches cause an effective decrease in func-
tional liver mass, a two-thirds PHx, in which three of the five lobes
of the (rodent) liver are resected, is often preferred because it
facilitates reproducibility, accuracy of timing of events, and the
absence of tissue damage to the remaining lobes.4
Following two-thirds PHx, hepatocytes are the first cells of the
liver to undergo DNA synthesis/replication within 24–36 h,
during which the liver approximately doubles in size. This is fol-
lowed by a second round of DNA synthesis/replication to establish
the pre-PHx hepatocyte population. The repopulation of other
hepatic cell populations, such as the biliary epithelium and
endothelial cells, typically occurs 2–3 days after PHx and 12–24 h
after the first round of hepatocyte proliferation.3–5 Regardless of
the insult leading to the reduction in functional mass, the regen-
eration process requires a highly coordinated processing of
cytokine, growth factor and metabolic networks.5 These mecha-
nisms are critical during the different stages of regeneration and
range from detecting decreases in functional hepatic mass,
through coordinated cell division and repopulation, and the ori-
entation and restoration of cell phenotype function.2,6
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Heterotrimeric guanine nucleotide regulatory proteins
(G-proteins) are ubiquitously expressed intracellular signalling
molecules that act as intermediates which transduce extracellular
signals to intracellular effectors via G-protein coupled receptors
(GPCRs).7 The intracellular pathways regulated following
G-protein subunit dissociation depend on the specific α-subunit
and/or βγ-dimer subunit compositions. For example, adenylyl
cyclase activity is, for the most part, regulated by the balance in
stimulatory (Gsα) and inhibitory (Giα) G-protein activation.
This, in turn, regulates the levels of intracellular cyclic adenosine
monophosphate (cAMP) and protein kinase A (PKA) activity, an
important regulator of cell function and gene transcription. Con-
versely, βγ-dimers associated (predominantly) with Giα-proteins
are important regulators of mitogen-activated protein kinase
(MAPK) signalling, a central regulator of cell proliferation.8,9
Given the widespread distribution of G-proteins and their roles in
regulating fundamental cell pathways and processes, it is of little
surprise that Gi/Gs-proteins are involved in liver regeneration
following PHx.10,11 Somewhat more surprising is the relative lack
of data identifying specific GPCRs that regulate intracellular
G-protein activity during regeneration.
Lysophosphatidic acid (LPA) is a small (450-Da), ubiquitously
expressed bioactive phospholipid12,13 derived from phospholipid
metabolism.14 Lysophosphatidic acid is present in all eukaryotic
tissue at low concentrations (pM–nM), and at higher concentra-
tions in blood plasma (sub-μM).13,14 Following synthesis, LPA
interacts with specific cell surface receptors (LPARs) to regulate
cell function. All LPARs identified to date are GPCRs and activate
a range of G-protein subtypes following LPA–LPAR binding.9,15
Signalling via LPA is involved in a diverse range of physiological
and pathological events, including neoangiogenesis, neuronal
growth, cardiovascular disease, fibrosis and cancer.12,13 In liver
biology and pathology, LPA is involved in mediating hepatic
myofibroblast migration,16 chemically induced liver injury,17,18 and
protecting against sepsis-induced liver damage.18 However, the
roles of specific LPARs in regulating events within the liver have
been more difficult to define because LPARs are generally not well
characterized1–5 in human and rodent liver.13
In 2008 a novel non-endothelial differentiation gene (EDG)
LPAR family member, LPAR6, was reported.19 Because of the
strong association between LPA and liver function, and the central
role for G-protein signalling during hepatic regeneration, the
present authors sought to determine whether PHx was associated
with changes in LPA and LPAR-subtype expression and localiza-
tion, including that of the most recently reported LPAR6 subtype,
in a mouse model of liver regeneration after PHx.
Materials and methods
Institutional assurances
Male C57BL/6 mice (aged 8–10 weeks) were purchased from
Jackson Laboratory (Bar Harbor, ME, USA). Studies were
approved by the Institutional Animal Care and Use Committee,
Carolinas Medical Center (Charlotte, NC, USA) and conformed
to the National Institutes of Health Guide for the Care and Use of
Laboratory Animals.
Materials
Extraction and purification of RNA were performed using TRIzol
(Invitrogen, Inc., Carlsbad, CA, USA). RQ1 DNase and the Improm-
II reverse transcription system were purchased from Promega Corp.
(Madison, WI, USA), and iQ SYBR Green Supermix was purchased
from Bio-Rad Laboratories, Inc., (Hercules, CA, USA). Antibodies
against proliferating cell nuclear antigen (PCNA) and LPAR6 were
purchased fromAbcam,Inc.(Cambridge,MA,USA),and antibodies
against LPAR1 and LPAR3 were purchased from Novus Biologicals,
Inc. (Littleton, CO, USA) and EMD Millipore Corp. (Billerica, MA,
USA), respectively. An enzyme-linked immunosorbent assay
(ELISA) to detect plasma LPA levels was purchased from Echelon
Biosciences, Inc. (Salt Lake City, UT, USA).
Partial hepatectomy
A two-thirds PHx was performed in male mice as previously
reported.20 Briefly, mice were anaesthetized using isoflurane by
inhalation and placed in a supine position on a warming pad. A
midline incision was made and the upper abdomen opened to
allow the falciform ligament to be divided to the level of the
superior vena cava. The lobes to be resected (the left lobe followed
by the median lobe) were gently lifted and a 4–0 silk suture placed
underneath the lobe as proximal to the origin as possible.
The suture was then tied at the base of the lobe and the lobe cut
distal to the suture. Resected tissue was weighed, cut and snap
frozen in liquid nitrogen or placed in neutral buffered formalin
prior to processing for mRNA analysis or histology and
immunohistochemistry (IHC). Mice received ∼ 0.7 ml of intra-
peritoneal sterile 0.9% saline to correct for fluid loss and the
abdominal muscle and skin were closed in two layers. At prede-
termined endpoints (12 h, 24 h, 48 h, 72 h, 96 h and 7 days post-
PHx) mice were killed by exsanguination, blood collected by
cardiac puncture and plasma prepared by centrifugation. Liver
tissue was removed, grossly examined, weighed, and either snap
frozen in liquid nitrogen or placed in neutral buffered formalin.21
Circulating LPA levels
Plasma was collected and analysed for circulating LPA levels using
a commercially available ELISA according to the manufacturer’s
instructions.
Tissue LPAR mRNA expression
Total RNA was extracted from flash frozen liver tissue and analysed
by quantitative reverse transcription polymerase chain reaction
using 50 ng cDNA and gene-specific oligonucleotide primers
(Table 1). Relative mRNA levels were calculated, normalized to
β-2-microglobulin (β2M, housekeeping gene), and expressed as
the fold change in expression for each LPAR subtype in regenerat-
ing liver samples relative to that in pair-matched liver tissue
obtained at the time of resection. Liver tissue from sham-operated
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animals was collected at 12 h post-surgery and analysed for
LPAR1–6 mRNA expression and findings were compared with
those in normal liver obtained at the time of resection. To directly
compare LPAR1, LPAR3 and LPAR6 mRNA expression, data were
normalized to β2M expression.21
Tissue histology and LPAR protein expression
Liver lobules were sectioned (4 μm) and stained with
haematoxylin and eosin (H&E); representative sections were
examined microscopically (original magnification: ×100).
Hepatic LPAR1, LPAR3 and LPAR6 expression and localiza-
tion in control (resected) and regenerating liver were established
by IHC as previously reported.21 Anti-LPAR1 was used at a
dilution of 1:100; anti-LPAR3 was used at a dilution of
1:200, and anti-LPAR6 was used at a dilution of 1:500. Five
random fields per slide were viewed and blind-scored using a
scale of 0–3 on which 0 represents the absence of detectable
stain.
Table 1 Forward and reverse primer sequences for lysophosphatidic acid receptors (LPARs) 1, 3, and 6 used for quantitative reverse
transcription polymerase chain reaction analysis
Gene Forward primer Reverse primer
LPAR1 5′ CTGCCTCTACTTCCAGCCCTGTAA 3′ 5′ TGCTCACTGTGTTCCATTCTGTGG 3′
LPAR3 5′ CCACTTTCCCTTCTACTACCTGCT 3′ 5′ GACGGTCAACGTTTTCGACACC 3′
LPAR6 5′ GATCACTCTCTGCATCGCTGTTTC 3′ 5′ CCCTGAACTTCAGAGAACCTGGAG 3′
β2M 5′ CTCGGTGACCCTGGTCTTTCTGGTG 3′ 5′ TCTCCGGTGGGTGGCGTGAGTATA 3′
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Figure 1 Hepatic regeneration following two-thirds partial hepatectomy (PHx) in male C57BL/6 mice. (a) Liver weights were obtained from
sham-operated (Sh) mice or following resection of the left and median hepatic lobes (Rs). Remnant/regenerating (Rg) liver weights were
obtained at 12 h, 24 h, 48 h, 72 h, 96 h and 7 days post-PHx. *, P < 0.05 versus sham liver weight; #, P < 0.05 Rs versus Rg; n = 5 animals
per time-point. (b) Representative immunohistochemistry images using an antibody specific against proliferating cell nuclear antigen (PCNA;
brown staining) in sections from Sh and Rg tissue at 24 h, 48 h and 7 days post PHx
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Statistics
Data are presented as the mean ± standard error of the mean
(SEM), as appropriate. Statistical analysis was performed using
GraphPad Prism Version 5.0b (GraphPad Software, Inc., La Jolla,
CA, USA). Group-wide analysis was performed by one-way analy-
sis of variance (anova). Pairwise combinations within a group
were analysed by paired Student’s t-test. A P-value of <0.05 was
considered to indicate statistical significance.
Results
Liver regeneration following two-thirds PHx
Resection of the left and median hepatic lobes resulted in a
decrease in liver weight of approximately 65% compared with
control (sham-operated) liver weight [mean resected liver weight:
0.81 ± 0.01 g (n = 30 samples); mean sham-operated liver weight:
1.24 ± 0.05 g (n = 4 samples); P < 0.05] (Fig. 1a). There was no
significant difference in mean animal weight (24.3 ± 0.3 g, n = 30),
or in the weight of resected liver tissue among animals
randomized to the six respective time-points (n = 5 animals per
time-point) (Fig. 1a). Prior to death, four animals appeared jaun-
diced and exhibited signs of distress, which led to their removal
from the study and replacement with additional animals. With the
exception of these four mice, H&E staining revealed normal
hepatic architecture and histology consistent with regenerating
liver tissue (data not shown). Immunohistochemical analysis
using an antibody against proliferating cell nuclear antigen
(PCNA) confirmed hepatic regeneration: intense nuclear PCNA
staining was detected at 24 h and 48 h post-PHx (Fig. 1b).
Partial hepatectomy leads to altered circulating
LPA levels
No significant difference in circulating LPA was detected over the
first 48 h in animals submitted to two-thirds PHx compared with
sham-operated animals (n = 5 per group) (Fig. 2). Conversely,
LPA increased significantly at 72 h post-PHx to 6.30 ± 0.67 μM
compared with 3.58 ± 0.37 μM in sham-operated animals (n = 5
per group; P < 0.05) (Fig. 2) and remained significantly elevated in
post-PHx liver compared with sham-operated liver for up to 7
days post-PHx (n = 5 per group; P < 0.05 at 96 h and 7 days)
(Fig. 2).
Partial hepatectomy alters hepatic LPAR1, LPAR3 and
LPAR6 mRNA expression
Quantitative reverse transcription polymerase chain reaction
analysis demonstrated LPAR2, LPAR4 and LPAR5 mRNA was
barely detectable, if at all, in normal liver, and did not significantly
change following PHx (data not shown). By contrast, LPAR1,
LPAR3 and LPAR6 mRNA was detected in sham-operated, resected
and regenerating liver tissue, and expression changed in a time-
dependent manner following PHx (Fig. 3a–c). Following resec-
tion, an initial peak in LPAR1 mRNA was detected at 12 h and 24 h,
followed by a second increase at 72 h and 96 h in regenerating liver
(n = 5 per time-point; P < 0.05 in regenerating liver versus pair-
matched resected liver) (Fig. 3a). By contrast, LPAR3 mRNA
expression increased sharply at 12 h, by approximately 10-fold, in
regenerating liver before returning to levels that did not signifi-
cantly differ from those in resected liver at the remainder of the
time-points analysed (24 h to 7 days) (n= 5 per time-point;P< 0.05
at 12 h post-PHx compared with pair-matched resected liver)
(Fig. 3b). Analysis of LPAR6 mRNA demonstrated a significant
increase in regenerating liver within 12 h of PHx, and LPAR6
mRNA remained significantly elevated at the remaining time-
points (24 h to 7 days) (n = 5 per time-point; P < 0.05, post-PHx
tissue versus pair-matched resected liver) (Fig. 3c). No significant
difference in LPAR1, LPAR3 or LPAR6 mRNA was detected
between sham-operated and resected liver tissue (data not shown).
A direct comparison of LPAR1, LPAR3 and LPAR6 levels demon-
strated significantly greater expression of LPAR6 mRNA than
LPAR1 mRNA or LPAR3 mRNA in both resected liver and regen-
erating liver at all time-points (n = 5 per time-point; P < 0.05 for
LPAR6 mRNA versus LPAR1 and LPAR3 mRNA at 24 h) (Fig. 3d).
Partial hepatectomy alters hepatic LPAR1, LPAR3 and
LPAR6 protein expression
No significant differences in LPAR1, LPAR3 or LPAR6 expression
were detected between sham-operated tissue and liver tissue
resected during PHx (data not shown). Analysis demonstrated
relatively low expression of LPAR1 in normal (sham-operated)
liver tissue (Fig. 4a, c). Following PHx, LPAR1 expression
increased significantly in regenerating tissue analysed at 48 h and
remained elevated at the remainder of the time-points analysed (n
= 5 per time-point; P < 0.05 at 48 h, 72 h, 96 h and 7 days in PHx
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Figure 2 Partial hepatectomy (PHx) leads to increased circulating
lysophosphatidic acid (LPA). Circulating LPA levels in sham-
operated (Sh) mice or mice following resection of the left and median
hepatic lobes. *, P < 0.05 versus sham-operated; n = 5 animals per
time-point
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versus sham-operated liver tissue) (Fig. 4c). Of particular note,
when LPAR1 expression was increased, detection appeared local-
ized to non-parenchymal cells (Fig. 4b, grey arrows). As with
LPAR1, LPAR3 was also relatively low in normal liver tissue and
increased at 48 h post-PHx (n = 5 per time-point; P < 0.05 at 48 h,
72 h, 96 h and 7 days in PHx versus sham-operated animals)
(Fig. 5a, c). Unlike LPAR1, LPAR3 appeared to be more widely
distributed (Fig. 5a, b). Finally, analysis of LPAR6 protein demon-
strated an initial modest, although significant, increase in expres-
sion within 12 h of PHx, before a second, more sustained increase
in expression was detected at 48 h post-PHx (n = 5 per time-point;
P < 0.05 at 12 h, 48 h, 72 h, 96 h and 7 days in PHx versus sham-
operated animals) (Fig. 6a, c). As with LPAR3, LPAR6 staining was
widely distributed (Fig. 6a, b).
Discussion
Hepatic regeneration following PHx requires complex, coordi-
nated signalling events.1–3,5 The aims of this study were to analyse
changes in LPAR signalling during hepatic regeneration in an
experimental mouse model, including that of the most recently
characterized LPAR isoform, LPAR6. The present paper reports
that the initiation of hepatic regeneration using a two-thirds PHx
model led to significantly increased levels of circulating LPA and
altered hepatic expression of LPAR1, LPAR3 and LPAR6. A role for
LPA–LPAR signalling has been indicated in a range of hepatic
disease states.16–18,21–23 However, previously characterized LPAR
subtypes (LPAR1–5) are expressed weakly, if at all, in the liver.
Thus identification of LPAR6 in normal liver, and subsequent
changes in expression during regeneration, may prove significant
in furthering current understanding of the role of LPA signalling
in liver physiology and pathology.
Several experimental approaches and rodent models of PHx
have been described. Using a model of 65–70% (two-thirds) PHx,
in which the left and median lobes were resected, the present
group first demonstrated the technical reproducibility of resection
and regeneration rates consistent with those reported by others.
Analysis of circulating LPA following PHx demonstrated a brief
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Figure 3 Partial hepatectomy (PHx) leads to altered lysophosphatidic acid receptor (LPAR) mRNA expression. Fold change in expression of
(a) LPAR1, (b) LPAR3 and (c) LPAR6 mRNA in regenerating liver tissue (Rg) and pair-matched resected liver (Rs) following two-thirds PHx.
*, P < 0.05 Rg versus Rs; n = 5 animals per time-point. (d) Relative expression of LPAR1, LPAR3 and LPAR6 mRNA in Rs and Rg liver tissue
at 24 h post-PHx. *, P < 0.05 LPAR6 mRNA versus corresponding (Rs and Rg) LPAR1 and LPAR3 mRNA expression; #, P < 0.05 Rg versus
Rs; n = 5 animals per time-point
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drop in LPA (at 12 h), followed by a return to baseline values (at
24–48 h) and a subsequent significant increase from 72 h until the
end of the experiment protocol (at 7 days). Using a rat model,
Watanabe et al. reported plasma LPA increased in response to 70%
PHx within 24 h.24 A possible explanation for this discrepancy
may lie in differences between the rat and mouse models of PHx
because cell replication occurs earlier in rats than in mice. Alter-
natively, Watanabe et al. employed a colorimetric enzymatic
cycling assay to detect LPA,24 whereas the present authors
employed a commercially available ELISA. This may be of par-
ticular significance for the detection of LPA because the term ‘LPA’
actually refers to a range of lipid-like substances formed following
phospholipid metabolism. As such, a number of LPA species with
widely differing biological properties can be formed.12–14 Because
the ELISA employed in the current study uses a single antibody to
detect LPA, it may not be sensitive to detect other earlier changes
in LPA subtype levels following PHx.12,25
Although it is possible that the ELISA employed was not suffi-
ciently sensitive to detect changes in different LPA subtypes follow-
ing PHx, other possibilities must also be considered. To date, the
role of LPA signalling in liver biology and pathology has been
ambiguous. Systemic LPA is reported to affect liver function and
changes in hepatic LPA-dependent signalling are reported in
response to physiological and pathological stressors. Conversely,
although the liver appears to be a target for LPA activity, previously
characterized LPARs 1–5 are weakly expressed or undetectable in
rodent and human liver. In line with these earlier reports,13,23 the
present authors detected LPAR1 and LPAR3 mRNA and protein,
albeit at relatively low levels, in normal mouse liver. By contrast,
LPAR6 mRNA was abundantly detectable in normal liver (relative
to LPAR1 and LPAR3 mRNA).
Following PHx, both LPAR1 mRNA and protein expression
increased significantly. Albeit that the corresponding increases in
LPAR1 protein were relatively modest, it was particularly interest-
ing to note that LPAR1 staining was confined to non-parenchymal
cells. Although the present study did not facilitate the further
identification of specific cell populations [hepatic stellate cells
(HSCs), endothelial cells, Kupffer cells], it is of interest to note that
other investigators report LPA stimulates proliferation26 and con-
traction27 of HSCs in vitro. This may be of further relevance in view
of the need to repopulate the liver with HSCs following regenera-
tion, and the role of HSCs in supporting the regenerative process
via the release of mitogens associated with hepatocyte growth, a
process that requires a transient change in HSC phenotype to an
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Figure 4 Partial hepatectomy (PHx) leads to altered lysophosphatidic acid receptor-1 (LPAR1) protein expression. (a) Representative
immunohistochemistry (IHC) images of sham-operated (Sh) or regenerating (Rg) liver tissue following two-thirds PHx analysed for LPAR1
expression (×200). (b) Representative IHC image of LPAR1 expression in regenerating liver at 48 h after two-thirds PHx (×400). Grey arrows
indicate non-parenchymal cell staining. (c) Representative fields (n = 5 per time-point) were blind scored on a scale of 0–3. *, P < 0.05 Rg
versus Sh; n = 5 animals per time-point
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activated state.28–30 Indeed, if cells staining for LPAR1 post-PHx are
HSCs, this may explain why a biphasic change in LPAR1 mRNA
occurs, in which the first increase (at 12–24 h) coincides with an
HSC-dependent mitogen release and the initial round of
hepatocyte proliferation, and the second increase (at 48 h to 7 days)
is involved in HSC repopulation.
Analysis of LPAR3 identified an increase in mRNA expression
within 12 h of PHx, followed by elevated protein expression at
48 h post-PHx. Although LPAR6 mRNA and protein also
increased within 12 h, unlike LPAR3 the increases in LPAR6
expression were sustained at later time-points (48 h to 7 days
post-PHx). Additionally, LPAR6 staining was more widespread
than that observed for LPAR1 or LPAR3. This may be of particular
significance in delineating a potential role for LPAR6-dependent
signalling in experimental models of PHx. Following two-thirds
PHx in mice, the initial round of hepatocyte proliferation peaks at
≈ 36 h, is followed by biliary epithelial cells and subsequently
sinusoidal endothelial cells concomitant with a second round of
hepatocyte repopulation.1–3,5 Because the present data demon-
strate that the most significant changes in LPA production and
LPAR expression do not occur until ≥48 h post-PHx, it would
seem fair to presume LPA–LPAR signalling is not a central media-
tor of initial hepatocyte repopulation. Rather, the current data
suggest that it is more likely that LPA–LPAR6 signalling mediates
proliferation of other hepatic cell populations or serves a function
other than that of a mitogenic factor in the regenerating liver.
Following regeneration/repopulation, it is important that cells
undergo differentiation to acquire the phenotype necessary to
perform the functions demanded of them. For example, a basic
physiological function of hepatocytes is the production, modifi-
cation and secretion of bile. For this to occur following hepatocyte
division, it is essential that not only are the biochemical and enzy-
matic processes needed to manufacture the components of bile
are restored, but that the hepatocyte also orientates correctly
within the sinusoid to form the basal (sinusoidal) and apical
(canalicular) membranes required for bile secretion. Similarly, for
repopulation to progress, it is necessary for basement membrane
remodelling to occur to generate the space which dividing
hepatocytes will occupy. Preliminary data indicate that LPAR6
activation leads to intracellular Rho activation or cAMP–PKA
signalling. Although this aspect requires more investigation, it is
interesting to note that Rho activation is widely implicated during
cell migration and mitogenesis,31 and cAMP–PKA signalling is
important to the process of hepatocyte orientation32,33 and to
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Figure 5 Partial hepatectomy (PHx) leads to altered lysophosphatidic acid receptor-3 (LPAR3) protein expression. (a) Representative
immunohistochemistry (IHC) images of sham-operated (Sh) or regenerating (Rg) liver tissue following two-thirds PHx analysed for LPAR3
expression (×200). (b) Representative IHC image of LPAR3 expression in regenerating liver at 48 h following two-thirds PHx (×400). (c)
Representative fields (n = 5 per time-point) were blind scored on a scale of 0–3. *, P < 0.05 Rg versus Sh; n = 5 animals per time-point
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water channel (aquaporin) localization within the basolateral and
canalicular membranes during bile production.34–36
The data presented herein suggest further investigation is war-
ranted to delineate the role of LPA–LPAR signalling during
hepatic growth and the restoration of cell function in the regen-
erating liver. In such investigations it may prove equally important
to consider other potential functions for LPA–LPAR signalling
during the restoration of functional liver mass. For example, the
(relatively) late changes in LPA–LPAR signalling that occur fol-
lowing PHx may indicate LPA signalling plays a role in other
important events, such as hepatic vascular remodelling and/or the
re-establishment of the three-dimensional architecture of the
sinusoid that is critical to the restoration of liver function. Indeed,
a significant body of literature has addressed the importance of
changes in blood volume and blood flow during regeneration
following PHx, and the impact of these factors in stimulating and
regulating the regenerative process.
Conclusions
The present data demonstrate that hepatic regeneration increases
circulating LPA and LPAR1, LPAR3 and LPAR6 expression in a
mouse model of PHx. Of particular note, changes in LPA and
LPAR expression were not detected until after the first round of
hepatocyte proliferation was complete, which suggests that LPA
may be involved in the proliferation of other hepatic cell types
and/or the restoration of cell function following initial hepatocyte
proliferation.
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